Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatic Hemodynamic Responses to Long-acting Octreotide in Cirrhosis
NCT01188733Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 1998
- Primary completion
- Jul 2000
- Modality
- Peptides
01
Overview
Phase 2, randomised trial of octreotide in Portal Hypertension (PH) and esophageal varices (3 arms), sponsored by Mayo Clinic. Primary endpoint: Portal pressure. Started Jun 1998; status: completed.
02
Drugs
octreotide
03
Conditions
Portal Hypertension (PH)esophageal varices
Beyond the preview
Go deeper on NCT01188733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188733.